STAT-4 immune modulators (Diakine)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSTAT-4 immune modulators (Diakine)
Drug Alias Namesecond generation analogs (Diakine)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSignal transducer and activator of transcription 4 modulators
TargetsSignal transducer and activator of transcription 4
Therapy Area/IndicationsDiabetes ComplicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDiakine Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDiakine Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsDiabetes ComplicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A